General Information of Drug (ID: DMIOUFK)

Drug Name
Emfilermin Drug Info
Synonyms AM-424; Leukemia inhibitory factor, AMRAD; RhLIF, AMRAD; RhLIF, Serono; Recombinant LIF protein, AMRAD/Serono; R-LIF, AMRAD/Serono
Indication
Disease Entry ICD 11 Status REF
Infertility GB04 Phase 1/2 [1]
Cross-matching ID
TTD Drug ID
DMIOUFK

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Leukemia inhibitory factor receptor (LIFR) TTID542 LIFR_HUMAN Inhibitor [2]

References

1 ClinicalTrials.gov (NCT00504530) r-hLIF for Improving Embryo Implantation in IVF. U.S. National Institutes of Health.
2 Population pharmacokinetic modelling of Emfilermin (recombinant human leukaemia inhibitory factor, r-hLIF) in healthy postmenopausal women and in infertile patients undergoing in vitro fertilization and embryo transfer. Br J Clin Pharmacol. 2004 May; 57(5): 576-585.